Literature DB >> 21479070

Enhancing oncologist participation in research.

.   

Abstract

Experienced clinical investigators share suggestions with oncologists wishing to become more involved in the research process.

Year:  2009        PMID： 21479070      PMCID： PMC2869181          DOI： 10.1200/JOP.091042

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  4 in total

1.  Oncologist's role critical to clinical trial enrollment.

Authors:  R Finn
Journal:  J Natl Cancer Inst       Date:  2000-10-18       Impact factor: 13.506

2.  Surveys identify barriers to participation in clinical trials.

Authors:  R Finn
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

3.  ASCO Outlines Minimum Standards and Exemplary Attributes for Research Sites: Previews Tools to Be Provided.

Authors: 
Journal:  J Oncol Pract       Date:  2008-07       Impact factor: 3.840

4.  American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Authors:  Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544
  4 in total
  1 in total

1.  Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Authors:  Howard A Zaren; Suresh Nair; Ronald S Go; Rebecca A Enos; Keith S Lanier; Michael A Thompson; Jinxiu Zhao; Deborah L Fleming; John C Leighton; Thomas E Gribbin; Donna M Bryant; Angela Carrigan; Jennifer C Corpening; Kimberly A Csapo; Eileen P Dimond; Christie Ellison; Maria M Gonzalez; Jodi L Harr; Kathy Wilkinson; Andrea M Denicoff
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.